223. Primary membranoproliferative glomerulonephritis
18 clinical trials, 14 drugs (DrugBank: 7 drugs), 7 drug target genes, 14 drug target pathways
Searched query = "Primary membranoproliferative glomerulonephritis", "Dense deposit disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00583427 (ClinicalTrials.gov) | December 2007 | 20/12/2007 | Sulodexide Treatment in Patients With Dense Deposit Disease | Sulodexide Treatment in Patients With Dense Deposit Disease | Dense Deposit Disease | Drug: Sulodexide | University of Iowa | NULL | Withdrawn | 5 Years | 20 Years | Both | 0 | Phase 1 | United States |